Department of General Orthopedics and Tumor Orthopedics, University Hospital Muenster, Muenster, Germany.
Arch Orthop Trauma Surg. 2012 Mar;132(3):405-10. doi: 10.1007/s00402-011-1351-0. Epub 2011 Jul 14.
The Burch-Schneider cage is an established implant in revision surgery after hip arthroplasty that is used for reconstructing osseous defects in the acetabulum. However, there are only a few reports about the use of cages in patients with metastatic destruction of the acetabulum. The aim of this retrospective study was to assess the outcome and complications of this procedure.
The records of 15 patients with metastatic acetabular defects using the Burch-Schneider cage were examined pre- and postoperatively. X-rays were analyzed, clinical and functional outcome was assessed by the Harris hip score (HHS) and the visual analogue scale (VAS) for subjective pain perception. The follow-up of 14 months was due to the underlying disease.
The overall revision rate was 26%. The HHS improved from 33 (range 25-39) to 69 (range 35-93). The VAS improved from 7.5 to 3.2.
The life expectancy of patients with bone metastasis can be short and patients should be carefully selected for a surgical treatment. The implantation of a protrusio cage can improve the quality of life in these patients by increasing their mobility and reducing pain. The complication rate is comparable with the rates for other surgical methods for metastatic acetabular lesions. For surgeons who are familiar with this implant, it seems to be a good option in treating such cases.
在髋关节置换术后的翻修手术中,Burch-Schneider cage 是一种成熟的植入物,用于重建髋臼的骨缺损。然而,只有少数关于在髋臼转移性破坏患者中使用 cage 的报道。本回顾性研究旨在评估该手术的结果和并发症。
检查了 15 例使用 Burch-Schneider cage 治疗髋臼转移性缺损的患者的术前和术后记录。分析 X 射线,通过 Harris 髋关节评分(HHS)和主观疼痛感知的视觉模拟量表(VAS)评估临床和功能结果。由于基础疾病,随访时间为 14 个月。
总的翻修率为 26%。HHS 从 33(范围 25-39)改善至 69(范围 35-93)。VAS 从 7.5 改善至 3.2。
骨转移患者的预期寿命可能较短,应仔细选择手术治疗。植入突出 cage 可以通过增加患者的活动能力和减轻疼痛来提高这些患者的生活质量。并发症发生率与其他治疗转移性髋臼病变的手术方法相当。对于熟悉这种植入物的外科医生来说,在治疗这种病例时,它似乎是一个不错的选择。